IN HB1445 | 2023 | Regular Session
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Republican 6-1)
Status: Passed on May 4 2023 - 100% progression
Action: 2023-05-04 - Public Law 233
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Moderate Partisan Bill (Republican 6-1)
Status: Passed on May 4 2023 - 100% progression
Action: 2023-05-04 - Public Law 233
Text: Latest bill text (Enrolled) [PDF]
Summary
Audit of Medicaid program prescription drug costs. Amends the requirements for a physician to provide office based opioid treatment. Provides that the attorney general may issue a request for proposal to audit the prescription drug programs within the state employee health plan and the Medicaid program. Provides that the attorney general may evaluate and determine whether to include specified metrics in the request for proposal. Provides that the audit look back period must be the previous five state fiscal years. Provides that the results of the audits must be provided to the interim study committee on public health, behavioral health, and human services before September 1, 2024. Provides that a practitioner is not required to obtain information about a patient from the Indiana scheduled prescription electronic collection and tracking program (INSPECT) data base or through the patient's integrated health record before prescribing certain medications if the patient is enrolled in a hospice program.
Title
Audit of Medicaid program prescription drug costs.
Sponsors
Rep. Ann Vermilion [R] | Rep. Matthew Lehman [R] | Rep. Martin Carbaugh [R] | Rep. Gregory Porter [D] |
Sen. Mike Bohacek [R] | Sen. Ed Charbonneau [R] | Sen. Andy Zay [R] |
Roll Calls
2023-04-28 - Senate - Senate - Rules Suspended. Conference Committee Report 1 (Y: 50 N: 0 NV: 0 Abs: 0) [PASS]
2023-04-27 - House - House - Rules Suspended. Conference Committee Report 1 (Y: 95 N: 0 NV: 1 Abs: 4) [PASS]
2023-04-18 - Senate - Senate - Third reading (Y: 50 N: 0 NV: 0 Abs: 0) [PASS]
2023-02-23 - House - House - Third reading (Y: 92 N: 0 NV: 4 Abs: 4) [PASS]
2023-04-27 - House - House - Rules Suspended. Conference Committee Report 1 (Y: 95 N: 0 NV: 1 Abs: 4) [PASS]
2023-04-18 - Senate - Senate - Third reading (Y: 50 N: 0 NV: 0 Abs: 0) [PASS]
2023-02-23 - House - House - Third reading (Y: 92 N: 0 NV: 4 Abs: 4) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-05-04 | House | Public Law 233 |
2023-05-04 | House | Signed by the Governor |
2023-05-01 | House | Signed by the Speaker |
2023-04-28 | Senate | Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 533: yeas 50, nays 0 |
2023-04-28 | Senate | Signed by the President of the Senate |
2023-04-28 | Senate | Signed by the President Pro Tempore |
2023-04-27 | House | Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 553: yeas 95, nays 0 |
2023-04-27 | Senate | CCR # 1 filed in the Senate |
2023-04-27 | House | CCR # 1 filed in the House |
2023-04-20 | Senate | Senate advisors appointed: Randolph Lonnie M, Charbonneau and Zay |
2023-04-20 | Senate | Senate conferees appointed: Bohacek and Qaddoura |
2023-04-19 | House | House advisors appointed: Carbaugh, Ledbetter and Fleming |
2023-04-19 | House | House conferees appointed: Vermilion and Porter |
2023-04-19 | House | House dissented from Senate amendments |
2023-04-19 | House | Motion to dissent filed |
2023-04-18 | Senate | Returned to the House with amendments |
2023-04-18 | Senate | Third reading: passed; Roll Call 439: yeas 50, nays 0 |
2023-04-17 | Senate | Second reading: ordered engrossed |
2023-04-13 | Senate | Committee report: amend do pass, adopted |
2023-03-30 | Senate | Committee report: do pass adopted; reassigned to Committee on Appropriations |
2023-03-06 | Senate | First reading: referred to Committee on Insurance and Financial Institutions |
2023-02-24 | House | Referred to the Senate |
2023-02-23 | House | Third reading: passed; Roll Call 224: yeas 92, nays 0 |
2023-02-23 | House | Senate sponsors: Senators Bohacek, Charbonneau, Zay |
2023-02-22 | House | Second reading: ordered engrossed |
2023-02-20 | House | Committee report: amend do pass, adopted |
2023-02-13 | House | Representatives Carbaugh and Porter added as coauthors |
2023-02-13 | House | Representative Schaibley removed as coauthor |
2023-02-07 | House | Referred to the Committee on Ways and Means pursuant to House Rule 127 |
2023-02-07 | House | Committee report: amend do pass, adopted |
2023-01-19 | House | Representative Schaibley added as coauthor |
2023-01-17 | House | First reading: referred to Committee on Public Health |
2023-01-17 | House | Authored by Representative Vermilion |
2023-01-17 | House | Coauthored by Representative Lehman |
Subjects
AUDITS AND AUDITORS
DRUGS AND MEDICINES
HEALTH, Health Care Costs; Health Insurance
LABOR AND EMPLOYMENT, Wages, Arbitration, and Benefits
WELFARE, Medicaid
DRUGS AND MEDICINES
HEALTH, Health Care Costs; Health Insurance
LABOR AND EMPLOYMENT, Wages, Arbitration, and Benefits
WELFARE, Medicaid